» Articles » PMID: 29531211

Added Value of NeuroGam Software Analysis in Single Photon Emission Computed Tomography Localization Diagnosis of Epilepsy in Interictal Stage

Overview
Journal Med Sci Monit
Date 2018 Mar 14
PMID 29531211
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND This study aimed to investigate the added value of NeuroGam software analysis in the localization diagnosis of epileptogenic zone during interictal phase of seizures. MATERIAL AND METHODS The clinical data of 67 patients, clinically diagnosed as epilepsy, were analyzed retrospectively. Visual analysis and NeuroGam software analysis were used for independent analysis. The 2 methods were used to compare the efficacy indicator of the diagnosis of epileptogenic zone, and the receiver operating characteristic (ROC) curve evaluated the diagnostic efficacy. RESULTS Through the final clinical diagnostic comprehensive localization, among 67 epilepsy patients, the epileptogenic zone in 51 cases could be located distinctly, and those in 16 cases could not be located. Compared to the visual analysis, the NeuroGam software analysis was more sensitive in the location of epileptogenic zone (χ²=4.876, P=0.027). The area under the ROC curve (AUC) and 95% confidence interval (CI) of the NeuroGam software and visual analyses was 0.760 and 0.689, (0.613, 0.908) and (0.547, 0.832), respectively. However, the consistency of the 2 methods was poor (Kappa=0.367, P=0.001). Compared to visual analysis, the NeuroGam software analysis exerted more advantages in the localization diagnosis of the epileptogenic zone (P<0.001). CONCLUSIONS In the location diagnosis of brain perfusion, single photon emission computed tomography (SPECT) epileptogenic zone was used in interictal phase of seizures, and NeuroGam software analysis exerted a distinct added value for visual analysis.

Citing Articles

Nuclear imaging for localization and surgical outcome prediction in epilepsy: A review of latest discoveries and future perspectives.

Sukprakun C, Tepmongkol S Front Neurol. 2023; 13:1083775.

PMID: 36588897 PMC: 9800996. DOI: 10.3389/fneur.2022.1083775.


MicroRNA-27a-3p Downregulation Inhibits Inflammatory Response and Hippocampal Neuronal Cell Apoptosis by Upregulating Mitogen-Activated Protein Kinase 4 (MAP2K4) Expression in Epilepsy: In Vivo and In Vitro Studies.

Lu J, Zhou N, Yang P, Deng L, Liu G Med Sci Monit. 2019; 25:8499-8508.

PMID: 31710596 PMC: 6865231. DOI: 10.12659/MSM.916458.

References
1.
Schrouff J, Rosa M, Rondina J, Marquand A, Chu C, Ashburner J . PRoNTo: pattern recognition for neuroimaging toolbox. Neuroinformatics. 2013; 11(3):319-37. PMC: 3722452. DOI: 10.1007/s12021-013-9178-1. View

2.
Paschali A, Messinis L, Lyros E, Constantoyannis C, Kefalopoulou Z, Lakiotis V . Neuropsychological functions and rCBF SPECT in Parkinson's disease patients considered candidates for deep brain stimulation. Eur J Nucl Med Mol Imaging. 2009; 36(11):1851-8. DOI: 10.1007/s00259-009-1168-z. View

3.
Lason W, Chlebicka M, Rejdak K . Research advances in basic mechanisms of seizures and antiepileptic drug action. Pharmacol Rep. 2013; 65(4):787-801. DOI: 10.1016/s1734-1140(13)71060-0. View

4.
Kerr M, Linehan C, Thompson R, Mula M, Gil-Nagal A, Zuberi S . A White Paper on the medical and social needs of people with epilepsy and intellectual disability: the Task Force on Intellectual Disabilities and Epilepsy of the International League Against Epilepsy. Epilepsia. 2014; 55(12):1902-6. DOI: 10.1111/epi.12848. View

5.
Fisher R, Scharfman H, deCurtis M . How can we identify ictal and interictal abnormal activity?. Adv Exp Med Biol. 2014; 813:3-23. PMC: 4375749. DOI: 10.1007/978-94-017-8914-1_1. View